Prize laureates

Three scientists whose work helped transform immune cells into powerful
cancer treatments have been named recipients of the 2026 Tang Prize in
Biopharmaceutical Science.

Steven A. Rosenberg, Michel Sadelain and Carl H. June were recognized for
developing immunotherapies that use a patient's own immune cells to fight
cancer.

The Tang Prize committee says their work has revolutionized treatment for a
range of blood cancers and solid tumors.

In interviews ahead of the announcement, the three researchers highlighted
the importance of perseverance, unconventional thinking and a commitment to
helping patients.

They also described years of setbacks and skepticism before their therapies
eventually proved successful.

The Tang Prize is awarded every two years to honor major achievements in
fields including sustainable development, biopharmaceutical science, sinology
and the rule of law.